Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    June 2022
  1. SCHATZ M
    Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2022;386:2139-2140.
    PubMed    


    May 2022
  2. PAPI A, Chipps BE, Beasley R, Panettieri RA Jr, et al
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2203163.
    PubMed     Abstract available


    April 2022
  3. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    PubMed    


    March 2022
  4. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    PubMed    


  5. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    PubMed    


  6. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    PubMed     Abstract available


    February 2022
  7. ISRAEL E, Cardet JC, Carroll JK, Fuhlbrigge AL, et al
    Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
    N Engl J Med. 2022 Feb 26. doi: 10.1056/NEJMoa2118813.
    PubMed     Abstract available


    January 2022
  8. BRUSSELLE GG, Koppelman GH
    Biologic Therapies for Severe Asthma.
    N Engl J Med. 2022;386:157-171.
    PubMed    


    December 2021
  9. GONZALEZ BURCHARD E, Borrell LN
    Need for Racial and Ethnic Diversity in Asthma Precision Medicine.
    N Engl J Med. 2021;385:2297-2298.
    PubMed    


  10. BACHARIER LB, Maspero JF, Katelaris CH, Fiocchi AG, et al
    Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:2230-2240.
    PubMed     Abstract available


  11. ZHANG B, Ma L
    Transverse Nasal Creases.
    N Engl J Med. 2021;385:2281.
    PubMed    


    October 2021
  12. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.
    PubMed    


  13. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    PubMed    


  14. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed     Abstract available


  15. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed     Abstract available


    September 2021
  16. MERGOUM AM
    Amoxicillin Rash in Infectious Mononucleosis.
    N Engl J Med. 2021;385:1033.
    PubMed    


  17. SALAS RN
    Environmental Racism and Climate Change - Missed Diagnoses.
    N Engl J Med. 2021;385:967-969.
    PubMed    


    June 2021
  18. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    PubMed    


  19. ROTHENBERG ME
    An Allergic Basis for Abdominal Pain.
    N Engl J Med. 2021;384:2156-2158.
    PubMed    


    May 2021
  20. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    PubMed    


  21. MENZIES-GOW A, Corren J, Bourdin A, Chupp G, et al
    Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
    N Engl J Med. 2021;384:1800-1809.
    PubMed     Abstract available


    April 2021
  22. ALVAREZ-ARANGO S, Ogunwole SM, Sequist TD, Burk CM, et al
    Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome".
    N Engl J Med. 2021;384:1283-1286.
    PubMed    


    March 2021
  23. STANDER S
    Atopic Dermatitis.
    N Engl J Med. 2021;384:1136-1143.
    PubMed    


  24. BIEBER T, Simpson EL, Silverberg JI, Thaci D, et al
    Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
    N Engl J Med. 2021;384:1101-1112.
    PubMed     Abstract available


    February 2021
  25. FIJEN LM, Stroes ESG, Cohn DM
    Control of Hereditary Angioedema. Reply.
    N Engl J Med. 2021;384:e11.
    PubMed    


  26. WANG C
    Control of Hereditary Angioedema.
    N Engl J Med. 2021;384:e11.
    PubMed    


  27. HOUCHENS N, Hartley S, Commins SP, Claar D, et al
    Hunting for a Diagnosis.
    N Engl J Med. 2021;384:462-467.
    PubMed    


    December 2020
  28. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
    PubMed    


  29. VIRKUD YV, Fernandes ND, Lim R, Mitchell DM, et al
    Case 39-2020: A 29-Month-Old Boy with Seizure and Hypocalcemia.
    N Engl J Med. 2020;383:2462-2470.
    PubMed    


    October 2020
  30. BERNSTEIN JA, Singh U, Rao MB, Berendts K, et al
    Benralizumab for Chronic Spontaneous Urticaria.
    N Engl J Med. 2020;383:1389-1391.
    PubMed    


    September 2020
  31. COHN DM, Viney NJ, Fijen LM, Schneider E, et al
    Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema.
    N Engl J Med. 2020;383:1242-1247.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: